ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Artificial intelligence (AI)
  • Brain cancer
  • Breast cancer
  • ComboMATCH
  • COVID-19
  • Gastrointestinal (GI) cancer
  • Genitourinary (GU) cancer
  • Head and neck cancer
  • Health equity
  • Imaging
  • Immunotherapy
  • In memory
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data
  • Real-world evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Young adults
February 11, 2026
nurse or caregiver using stethoscope to examine senior man at home
February 11, 2026
Categories
  • Ongoing Trials

Ongoing Trial: The ACHIEVE research study is comparing two treatment approaches for older adults with advanced non-small cell lung cancer

This trial aims to help patients aged 70 and older live longer while also maintaining a good quality of life
Do you like it?
0 Read more
February 11, 2026
Research dictionary entry
February 11, 2026
Categories
  • Trial Results

Top 10 cancer research discoveries of 2025

A year of progress by ECOG-ACRIN and PrECOG in breast cancer, leukemia, lung cancer, and melanoma
Do you like it?
0 Read more
November 3, 2025
Research dictionary entry
November 3, 2025
Categories
  • Trial Results

Trial Results: ECOG-ACRIN research round-up – Fall 2025

The latest discoveries from breast, leukemia, lung, nose/sinus, skin, and throat cancer clinical trials
Do you like it?
0 Read more
July 24, 2025
July 24, 2025
Categories
  • New Trials

Now Enrolling: The CLEAR research study is testing a new treatment combination for patients with operable non-small cell lung cancer

This clinical trial aims to improve treatment for high-risk patients by adding a targeted therapy to standard post-surgery immunotherapy
Do you like it?
0 Read more
123
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc